"10.1371_journal.pgen.1002078","plos genetics","2011-05-26T00:00:00Z","Federico Innocenti; Gregory M Cooper; Ian B Stanaway; Eric R Gamazon; Joshua D Smith; Snezana Mirkov; Jacqueline Ramirez; Wanqing Liu; Yvonne S Lin; Cliona Moloney; Shelly Force Aldred; Nathan D Trinklein; Erin Schuetz; Deborah A Nickerson; Ken E Thummel; Mark J Rieder; Allan E Rettie; Mark J Ratain; Nancy J Cox; Christopher D Brown","Cancer Research Center, Committee on Clinical Pharmacology and Pharmacogenomics, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America; Section of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America; Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, Washington, United States of America; Department of Pharmaceutics, University of Washington, Seattle, Washington, United States of America; Merck Research Laboratories, Boston, Massachusetts, United States of America; SwitchGear Genomics, Menlo Park, California, United States of America; Department of Pharmaceutical Sciences, St. Jude Childrens Research Hospital, Memphis, Tennessee, United States of America; Institute for Genomics and Systems Biology, The University of Chicago and Argonne National Laboratory, Chicago, Illinois, United States of America; Departments of Human Genetics and Ecology and Evolution, The University of Chicago, Chicago, Illinois, United States of America","Â¤ Current address: Hudson Alpha Institute, Huntsville, Alabama, United States of America","The authors ND Trinklein and SF Aldred are employees of and hold stock in SwitchGear Genomics. SwitchGear Genomics sells reporter vectors commercially and is the owner by assignment of patents or patent applications related to the reporter platform. The author C Moloney is an employee of Merck Research Labs.","2011","05","Federico Innocenti","FI",20,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
